CME Group Inc. $CME Stock Acquired by Mather Group LLC.

Mather Group LLC. lifted its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 162.1% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,728 shares of the financial services provider’s stock after buying an additional 4,161 shares during the quarter. Mather Group LLC.’s holdings in CME Group were worth $1,763,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of CME. First Pacific Financial lifted its stake in shares of CME Group by 449.3% in the third quarter. First Pacific Financial now owns 379 shares of the financial services provider’s stock valued at $99,000 after purchasing an additional 310 shares during the period. Fortitude Family Office LLC boosted its holdings in CME Group by 333.8% during the third quarter. Fortitude Family Office LLC now owns 577 shares of the financial services provider’s stock worth $151,000 after buying an additional 444 shares in the last quarter. Godsey & Gibb Inc. boosted its holdings in CME Group by 1.2% during the third quarter. Godsey & Gibb Inc. now owns 72,162 shares of the financial services provider’s stock worth $18,905,000 after buying an additional 852 shares in the last quarter. Columbus Macro LLC acquired a new position in CME Group during the third quarter worth about $6,523,000. Finally, Union Savings Bank grew its position in CME Group by 18.1% during the third quarter. Union Savings Bank now owns 1,487 shares of the financial services provider’s stock worth $360,000 after buying an additional 228 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insiders Place Their Bets

In related news, CEO Terrence A. Duffy sold 15,000 shares of the company’s stock in a transaction that occurred on Thursday, September 10th. The shares were sold at an average price of $274.44, for a total transaction of $4,116,600.00. Following the transaction, the chief executive officer owned 40,630 shares of the company’s stock, valued at approximately $11,150,497.20. This represents a 26.96% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director William R. Shepard bought 293 shares of the firm’s stock in a transaction that occurred on Friday, September 25th. The shares were purchased at an average price of $268.76 per share, for a total transaction of $78,746.68. Following the transaction, the director owned 263,289 shares of the company’s stock, valued at $70,761,551.64. The trade was a 0.11% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 0.30% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on CME shares. Raymond James Financial reaffirmed an “outperform” rating and issued a $320.00 target price on shares of CME Group in a report on Thursday, July 2nd. Deutsche Bank Aktiengesellschaft downgraded shares of CME Group from a “buy” rating to a “hold” rating and reduced their price target for the company from $286.00 to $270.00 in a research report on Wednesday, August 19th. Barclays boosted their price target on CME Group from $270.00 to $281.00 and gave the stock an “equal weight” rating in a research note on Wednesday, October 7th. Wall Street Zen upgraded CME Group from a “strong sell” rating to a “sell” rating in a report on Saturday, October 3rd. Finally, UBS Group raised their price objective on CME Group from $260.00 to $270.00 and gave the company a “neutral” rating in a research note on Monday, October 5th. Nine analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, CME Group has an average rating of “Hold” and an average target price of $292.94.

Check Out Our Latest Stock Report on CME

CME Group Price Performance

Shares of NASDAQ CME traded up $4.41 during trading on Friday, reaching $293.87. The company had a trading volume of 2,180,230 shares, compared to its average volume of 1,887,081. CME Group Inc. has a twelve month low of $218.31 and a twelve month high of $329.16. The stock has a market capitalization of $105.67 billion, a PE ratio of 24.93, a price-to-earnings-growth ratio of 3.79 and a beta of 0.24. The stock has a 50-day moving average price of $274.12 and a two-hundred day moving average price of $270.77. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME – Get Free Report) last issued its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.91 by $0.08. The business had revenue of $1.71 billion for the quarter, compared to the consensus estimate of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%. The business’s revenue was up .8% on a year-over-year basis. During the same period in the prior year, the business earned $2.96 earnings per share. As a group, sell-side analysts predict that CME Group Inc. will post 12.29 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th were paid a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a dividend yield of 1.8%. The ex-dividend date of this dividend was Wednesday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 44.11%.

CME Group Profile

(Free Report)

CME Group Inc operates global derivatives marketplaces that enable customers to manage risk and trade futures and options contracts. Its exchanges offer products linked to interest rates, equity indexes, foreign currencies, agricultural commodities, energy, metals and other asset classes.

The company also provides central counterparty clearing, settlement and related risk-management services for transactions conducted on its markets. In addition, CME Group offers market data, benchmark products and technology services that support trading, analysis and connectivity for financial institutions, businesses, professional traders and other market participants.

CME Group’s history includes the Chicago Board of Trade, founded in 1848, and the Chicago Mercantile Exchange, established in 1898.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.